Meeting of the Community Preventive Services Task Force (Task Force), 56586-56587 [2014-22502]
Download as PDF
<![CDATA[
56586
Federal Register / Vol. 79, No. 183 / Monday, September 22, 2014 / Notices
designs that address: The target
population to which generalizations
will be made, the sampling frame, the
sample design (including stratification
and clustering), the precision
requirements or power calculations that
justify the proposed sample size, the
expected response rate, methods for
assessing potential non-response bias,
the protocols for data collection, and
any testing procedures that were or will
be undertaken prior fielding the study.
Depending on the degree of influence
the results are likely to have, such
collections may still be eligible for
submission for other generic
mechanisms that are designed to yield
quantitative results.
Below we provide AHRQ’s projected
average annual estimates for the next
three years:
Current Actions: New collection of
information.
Type of Review: New Collection.
Affected Public: Individuals and
Households, Businesses and
Organizations, State, Local or Tribal
Government.
Average Expected Annual Number of
activities: 10.
Respondents: 10,900.
Annual responses: 10,900.
Frequency of Response: Once per
request.
The total number of respondents
across all 10 activities in a given year is
10,900.
Average minutes per response: 19.
Burden hours: 3,452.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
VerDate Sep<11>2014
17:07 Sep 19, 2014
Jkt 232001
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
Public record.
Dated: September 11, 2014.
Richard Kronick,
Director.
[FR Doc. 2014–22214 Filed 9–19–14; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Community Preventive
Services Task Force (Task Force)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC)
announces the next meeting of the
Community Preventive Services Task
Force (Task Force). The Task Force is an
independent, nonpartisan, nonfederal,
and unpaid panel. Its members
represent a broad range of research,
practice, and policy expertise in
prevention, wellness, health promotion,
and public health, and are appointed by
the CDC Director. The Task Force was
convened in 1996 by the Department of
Health and Human Services (HHS) to
identify community preventive
programs, services, and policies that
increase healthy longevity, save lives
and dollars and improve Americans’
quality of life. CDC is mandated to
provide ongoing administrative,
research, and technical support for the
operations of the Task Force. During its
meetings, the Task Force considers the
findings of systematic reviews on
existing research, and issues
recommendations. Task Force
recommendations provide information
about evidence-based options that
decision makers and stakeholders can
consider when determining what best
meets the specific needs, preferences,
available resources, and constraints of
their jurisdictions and constituents. The
Task Force’s recommendations, along
with the systematic reviews of the
scientific evidence on which they are
based, are compiled in the Guide to
Community Preventive Services
(Community Guide).
DATES: The meeting will be held on
Wednesday, October 29, 2014 from 8:30
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
a.m. to 6:00 p.m. EDT and Thursday,
October 30, 2014 from 8:30 a.m. to 1:00
p.m. EDT.
ADDRESSES: The Task Force Meeting
will be held at CDC Edward R. Roybal
Campus, Tom Harkin Global
Communications Center (Building 19),
1600 Clifton Road NE., Atlanta, GA
30333. You should be aware that the
meeting location is in a Federal
government building; therefore, Federal
security measures are applicable. For
additional information, please see
Roybal Campus Security Guidelines
under SUPPLEMENTARY INFORMATION.
Information regarding meeting logistics
will be available on the Community
Guide Web site
(www.thecommunityguide.org).
Meeting Accessibility: This meeting is
open to the public, limited only by
space availability in the meeting
location. All meeting attendees must
RSVP to ensure the required security
procedures are completed to gain access
to the CDC’s Global Communications
Center.
U.S. citizens must RSVP by 10/03/
2014.
Non U.S. citizens must RSVP by 9/26/
2014 due to additional security steps
that must be completed.
In addition to in-person participation,
individuals may view presentations via
live video stream on the Internet. Those
interested in accessing the live stream
must also RSVP, and additional
information will be sent to registrants
requesting connectivity via the Internet
in advance of the meeting. Failure to
RSVP by the dates identified could
result in an inability to attend the Task
Force meeting due to the strict security
regulations on federal facilities.
FOR FURTHER INFORMATION AND TO RSVP
CONTACT: Terica Scott, The Community
Guide Branch; Division of
Epidemiology, Analysis, and Library
Services; Center for Surveillance,
Epidemiology and Laboratory Services;
Office of Public Health Scientific
Services; Centers for Disease Control
and Prevention, 1600 Clifton Road, MS–
E–69, Atlanta, GA 30333, phone: (404)
498–6360, email: CPSTF@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The purpose of the meeting
is for the Task Force to consider the
findings of systematic reviews and issue
findings and recommendations. Task
Force recommendations provide
information about evidence-based
options that decision makers and
stakeholders can consider when
determining what best meets the
specific needs, preferences, available
resources, and constraints of their
jurisdictions and constituents.
E:\FR\FM\22SEN1.SGM
22SEN1
Federal Register / Vol. 79, No. 183 / Monday, September 22, 2014 / Notices
Matters to be discussed: Diabetes,
cardiovascular disease, and promoting
health equity. Topics are subject to
change.
Roybal Campus Security Guidelines:
The Edward R. Roybal Campus is the
headquarters of the U.S. Centers for
Disease Control and Prevention and is
located at 1600 Clifton Road NE.,
Atlanta, Georgia. The meeting is being
held in a Federal government building;
therefore, Federal security measures are
applicable.
All meeting attendees must RSVP by
the dates outlined under Meeting
Accessability. In planning your arrival
time, please take into account the need
to park and clear security. All visitors
must enter the Roybal Campus through
the entrance on Clifton Road. Your car
may be searched, and the guard force
will then direct visitors to the
designated parking area. Upon arrival at
the facility, visitors must present
government issued photo identification
(e.g., a valid federal identification
badge, state driver’s license, state nondriver’s identification card, or passport).
Non-United States citizens must
complete the required security
paperwork prior to the meeting date and
must present a valid passport, visa,
Permanent Resident Card, or other type
of work authorization document upon
arrival at the facility. All persons
entering the building must pass through
a metal detector. Visitors will be issued
a visitor’s ID badge at the entrance to
Building 19 and may be escorted to the
meeting room. All items brought to
HHS/CDC are subject to inspection.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0487]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Food and Drug
Administration Service Delivery
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(PRA).
SUMMARY:
Fax written comments on the
collection of information by October 22,
2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0697. Also
include the FDA docket number found
in brackets in the heading of this
document.
DATES:
[FR Doc. 2014–22502 Filed 9–19–14; 8:45 am]
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
BILLING CODE 4163–18–P
SUPPLEMENTARY INFORMATION:
Dated: September 17, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Generic Clearance for the Collection of
Qualitative Feedback on FDA Service
Delivery—(OMB Control Number 0910–
0697)—Extension
The information collection activity
will garner qualitative customer and
stakeholder feedback in an efficient,
VerDate Sep<11>2014
17:07 Sep 19, 2014
Jkt 232001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
56587
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback, FDA means
information that provides useful insight
on perceptions and opinions, not
statistical surveys that yield quantitative
results that can be generalized to the
population of study. This feedback will
provide insight into customer or
stakeholder perceptions; experiences
and expectations; provide an early
warning of issues with service; or focus
attention on areas where
communication, training, or changes in
operations might improve delivery of
products or services. This information
collection will allow for ongoing
collaborative and actionable
communications among the FDA and its
customers and stakeholders. It will also
allow feedback to contribute directly to
the improvement of program
management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address the
following: The target population to
which the generalizations will be made,
the sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
the methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
In the Federal Register of April 29,
2014 (79 FR 23980), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 79, Number 183 (Monday, September 22, 2014)]
[Notices]
[Pages 56586-56587]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22502]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Community Preventive Services Task Force (Task
Force)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) announces
the next meeting of the Community Preventive Services Task Force (Task
Force). The Task Force is an independent, nonpartisan, nonfederal, and
unpaid panel. Its members represent a broad range of research,
practice, and policy expertise in prevention, wellness, health
promotion, and public health, and are appointed by the CDC Director.
The Task Force was convened in 1996 by the Department of Health and
Human Services (HHS) to identify community preventive programs,
services, and policies that increase healthy longevity, save lives and
dollars and improve Americans' quality of life. CDC is mandated to
provide ongoing administrative, research, and technical support for the
operations of the Task Force. During its meetings, the Task Force
considers the findings of systematic reviews on existing research, and
issues recommendations. Task Force recommendations provide information
about evidence-based options that decision makers and stakeholders can
consider when determining what best meets the specific needs,
preferences, available resources, and constraints of their
jurisdictions and constituents. The Task Force's recommendations, along
with the systematic reviews of the scientific evidence on which they
are based, are compiled in the Guide to Community Preventive Services
(Community Guide).
DATES: The meeting will be held on Wednesday, October 29, 2014 from
8:30 a.m. to 6:00 p.m. EDT and Thursday, October 30, 2014 from 8:30
a.m. to 1:00 p.m. EDT.
ADDRESSES: The Task Force Meeting will be held at CDC Edward R. Roybal
Campus, Tom Harkin Global Communications Center (Building 19), 1600
Clifton Road NE., Atlanta, GA 30333. You should be aware that the
meeting location is in a Federal government building; therefore,
Federal security measures are applicable. For additional information,
please see Roybal Campus Security Guidelines under SUPPLEMENTARY
INFORMATION. Information regarding meeting logistics will be available
on the Community Guide Web site (www.thecommunityguide.org).
Meeting Accessibility: This meeting is open to the public, limited
only by space availability in the meeting location. All meeting
attendees must RSVP to ensure the required security procedures are
completed to gain access to the CDC's Global Communications Center.
U.S. citizens must RSVP by 10/03/2014.
Non U.S. citizens must RSVP by 9/26/2014 due to additional security
steps that must be completed.
In addition to in-person participation, individuals may view
presentations via live video stream on the Internet. Those interested
in accessing the live stream must also RSVP, and additional information
will be sent to registrants requesting connectivity via the Internet in
advance of the meeting. Failure to RSVP by the dates identified could
result in an inability to attend the Task Force meeting due to the
strict security regulations on federal facilities.
FOR FURTHER INFORMATION AND TO RSVP CONTACT: Terica Scott, The
Community Guide Branch; Division of Epidemiology, Analysis, and Library
Services; Center for Surveillance, Epidemiology and Laboratory
Services; Office of Public Health Scientific Services; Centers for
Disease Control and Prevention, 1600 Clifton Road, MS-E-69, Atlanta, GA
30333, phone: (404) 498-6360, email: CPSTF@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The purpose of the meeting is for the Task Force to
consider the findings of systematic reviews and issue findings and
recommendations. Task Force recommendations provide information about
evidence-based options that decision makers and stakeholders can
consider when determining what best meets the specific needs,
preferences, available resources, and constraints of their
jurisdictions and constituents.
[[Page 56587]]
Matters to be discussed: Diabetes, cardiovascular disease, and
promoting health equity. Topics are subject to change.
Roybal Campus Security Guidelines: The Edward R. Roybal Campus is
the headquarters of the U.S. Centers for Disease Control and Prevention
and is located at 1600 Clifton Road NE., Atlanta, Georgia. The meeting
is being held in a Federal government building; therefore, Federal
security measures are applicable.
All meeting attendees must RSVP by the dates outlined under Meeting
Accessability. In planning your arrival time, please take into account
the need to park and clear security. All visitors must enter the Roybal
Campus through the entrance on Clifton Road. Your car may be searched,
and the guard force will then direct visitors to the designated parking
area. Upon arrival at the facility, visitors must present government
issued photo identification (e.g., a valid federal identification
badge, state driver's license, state non-driver's identification card,
or passport). Non-United States citizens must complete the required
security paperwork prior to the meeting date and must present a valid
passport, visa, Permanent Resident Card, or other type of work
authorization document upon arrival at the facility. All persons
entering the building must pass through a metal detector. Visitors will
be issued a visitor's ID badge at the entrance to Building 19 and may
be escorted to the meeting room. All items brought to HHS/CDC are
subject to inspection.
Dated: September 17, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease
Control and Prevention.
[FR Doc. 2014-22502 Filed 9-19-14; 8:45 am]
BILLING CODE 4163-18-P
